What do systematic reviews say?

Myofunctional therapy vs sham

• Myofunctional therapy (oropharyngeal exercises) for obstructive sleep apnoea 2020 · Cochrane Headline outcomes only
  no estimate extracted
  2 studies · 82 participants
  Moderate

Myofunctional therapy vs CPAP + Myofunctional therapy

• Myofunctional therapy (oropharyngeal exercises) for obstructive sleep apnoea 2020 · Cochrane Headline outcomes only
  no estimate extracted
  1 study · 49 participants
  Low

Myofunctional therapy vs respiratory exercises + nasal dilator strip

• Myofunctional therapy (oropharyngeal exercises) for obstructive sleep apnoea 2020 · Cochrane Headline outcomes only
  no estimate extracted
  1 study · 58 participants
  Low

Myofunctional therapy vs medical treatment

• Myofunctional therapy (oropharyngeal exercises) for obstructive sleep apnoea 2020 · Cochrane Headline outcomes only
  no estimate extracted
  1 study · 26 participants
  Low

Myofunctional therapy vs waiting list control

• Myofunctional therapy (oropharyngeal exercises) for obstructive sleep apnoea 2020 · Cochrane Headline outcomes only
  no estimate extracted
  1 study · 25 participants
  Low

Myofunctional therapy vs continuous positive airway pressure (CPAP)

• Myofunctional therapy (oropharyngeal exercises) for obstructive sleep apnoea 2020 · Cochrane Headline outcomes only
  no estimate extracted
  1 study · 54 participants
  Low

Targeted individualized vs standard non‐individualized fortification

• Individualized versus standard diet fortification for growth and development in preterm infants receiving human milk 2020 · Cochrane Headline outcomes only
  no estimate extracted
  1 study · 75 participants
  Very low

Early full enteral feeding vs delayed or progressive feeding

• Early full enteral feeding for preterm or low birth weight infants 2020 · Cochrane Headline outcomes only
  no estimate extracted
  2 studies · 236 participants
  Very low

Strategies to increase use of antenatal corticosteroids vs usual care

Strategies to increase use of antenatal corticosteroids probably leads to higher neonatal death before 28 days (at population level) compared with routine (usual) care (moderate certainty).

• Strategies for optimising antenatal corticosteroid administration for women with anticipated preterm birth 2020 · Cochrane Headline outcomes only
  RR 1.12 [1.02, 1.23]
  1 study · 100705 participants
  Moderate

Digital targeted client communication via mobile devices vs non‐digital targeted client communication (pregnant and postpartum women)

Digital targeted client communication via mobile devices may leads to lower health status and well‐being – maternal mortality and morbidity… compared with non‐digital targeted client communication (pregnant and postpartum… (low certainty).

• Targeted client communication via mobile devices for improving maternal, neonatal, and child health 2020 · Cochrane Headline outcomes only
  RR 0.19 [0.04, 0.79]
  1 study · 59 participants
  Low

Digital targeted client communication via mobile devices vs non‐digital targeted client communication (pregnant and postpartum women)

Digital targeted client communication via mobile devices showed no clear difference in health status and well‐being – neonatal mortality and morbidity… compared with non‐digital targeted client communication (pregnant and postpartum… (low certainty).

• Targeted client communication via mobile devices for improving maternal, neonatal, and child health 2020 · Cochrane Headline outcomes only
  RR 0.52 [0.25, 1.06]
  1 study · 59 participants
  Low

Intervention not reported

• Oxygen targets in the intensive care unit during mechanical ventilation for acute respiratory distress syndrome: a… 2020 · Cochrane Headline outcomes only
  no estimate extracted
  1 study · 201 participants
  Very low

Intervention not reported

• Oxygen targets in the intensive care unit during mechanical ventilation for acute respiratory distress syndrome: a… 2020 · Cochrane Headline outcomes only
  no estimate extracted
  1 study · 201 participants
  Very low

Surgical removal (extraction) of asymptomatic disease-free impacted wisdom teeth vs Retention (conservative management) of asymptomatic disease-free impacted wisdom teeth

The review found no eligible studies for this question.

• Surgical removal versus retention for the management of asymptomatic disease‐free impacted wisdom teeth 2020 · Cochrane All outcomes
  Costs: Not measured. The included studies did not measure days off work/study or direct costs associated with retention or removal of wisdom teeth and treatment of associated symptoms or complications.
  0 studies
  No studies found

NSAIDs vs ethamsylate (control)

• Non‐steroidal anti‐inflammatory drugs for heavy menstrual bleeding 2019 · Cochrane Headline outcomes only
  no estimate extracted
  1 study · 46 participants
  Low

NSAIDs vs danazol (control)

• Non‐steroidal anti‐inflammatory drugs for heavy menstrual bleeding 2019 · Cochrane Headline outcomes only
  no estimate extracted
  2 studies · 53 participants
  Moderate

NSAIDs vs oral progestogens (control)

• Non‐steroidal anti‐inflammatory drugs for heavy menstrual bleeding 2019 · Cochrane Headline outcomes only
  no estimate extracted
  2 studies · 48 participants
  Moderate

NSAIDs vs progesterone‐releasing intrauterine system (control)

• Non‐steroidal anti‐inflammatory drugs for heavy menstrual bleeding 2019 · Cochrane Headline outcomes only
  no estimate extracted
  1 study · 16 participants
  Low

NSAIDs vs oral contraceptive pill (control)

The review found no eligible studies for this question.

• Non‐steroidal anti‐inflammatory drugs for heavy menstrual bleeding 2019 · Cochrane Headline outcomes only
  no estimate extracted
  Studies not reported
  No studies found

Mefenamic acid vs naproxen

• Non‐steroidal anti‐inflammatory drugs for heavy menstrual bleeding 2019 · Cochrane Headline outcomes only
  no estimate extracted
  1 study · 35 participants
  Low